Top Stories
-
Caghan Kizil, PhD, MSc, Associate Professor of Neurological Sciences (in Neurology & in the Taub Institute) and colleagues discovered a mechanism that promotes neurogenesis in the zebrafish brain
Topic
-
Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology and Neurology at CUMC, discusses, based on a new study, how eye drops could be more effective in treating retinal vein occlusion
Topic
-
Dr. Lawrence S. Honig, Professor of Neurology at the CUIMC, comments on the significance of Food and Drug Administration approval of the Alzheimer’s disease drug, Lecanemab
-
Lawrence S. Honig, MD, PhD, Professor of Neurology at the CUIMC, an investigator for the study that led to the FDA’s approval of Leqembi expresses his opinions about the new Alzheimer’s Disease drug
Topic
Latest News
- July 17, 2023
Jennifer J. Manly, PhD, Professor of Neuropsychology, and Lawrence S. Honig, MD, PhD, Professor of Neurology, comment on donanemab, the second Alzheimer’s drug
- July 6, 2023
Lawrence S. Honig, MD, PhD, a professor of neurology at CUIMC, estimates that group constitutes about a sixth of the more than 6 million Americans currently diagnosed with Alzheimer’s
- May 23, 2023
Stephanie Cosentino, PhD, Associate Professor of Neuropsychology, and colleagues are working on developing screening tools to detect subjective cognitive decline and more advanced forms of memory loss
Topic
- May 2, 2023
A new study done by Dr. Jennifer Manly, professor of neuropsychology, and colleagues, found that the quality of the high school you attend may have an impact on cognition later in life
Topic
- April 20, 2023
Richard Mayeux, MD, chair of the Department of Neurology at CUMC and colleagues are investigating a set of blood tests that may help correctly diagnose Alzheimer disease in low-resource environments
Topic
- February 27, 2023
Many people live years or even decades with dementia, which causes death. Researching the symptoms and causes can dramatically help dementia care and prevention.
- February 19, 2023
As Davangere Devanand, a neurologist at CUIMC, combed through the reams of scientific data on Alzheimer’s, he stumbled across a surprising idea – could an infection be involved in driving the disease?
- February 3, 2023
Of all the possible contributors, intense physical activity was the likely disease-modifying factor, Davangere Devanand, MD, of CUIMC, and co-authors wrote in Alzheimer's & Dementia
- September 28, 2022
Dr. Lawrence Honig, professor of neurology at Columbia University Irving Medical Center, speaks about the new Alzheimer drug trial results
- July 25, 2022
"Hispanics and individuals of African ancestry have been significantly underrepresented in research of Alzheimer’s disease, although engaging underserved minorities is critical..." says Dr. Reitz
Topic
